Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial - Concepedia

Concepedia

Publication | Open Access

Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial

DOI Full Paper Access

174

Citations

31

References

2018

Year

Gideon M. Hirschfield, Olivier Chazouillères, Joost P.H. Drenth, Douglas Thorburn, Stephen A. Harrison, Charles Landis, Marlyn J. Mayo, Andrew J. Muir, James F. Trotter, Diana Julie Leeming,

Journal of Hepatology

References

	Year	Citations

Page 1